FDA seeking to minimize supply impact of tornado damage to Pfizer site

The US Food and Drug Administration (FDA) is working closely with Pfizer NYSE: PFE) to assess the impact of the damage at its facility at Rocky Mount, North Carolina.

A tornado hit the site last week and reports on how much damage was done - and what the impact on the supply line will be - have varied.

Over the next few days, the FDA vowed to complete a more extensive assessment of the products that may be impacted and the current available supply of those products.